CD8+ T Cells Contribute to the Development of Coronary Arteritis in the Lactobacillus casei Cell Wall Extract–Induced Murine Model of Kawasaki Disease

Kawasaki disease (KD) is the leading cause of acquired heart disease among children in developed countries. Coronary lesions in KD in humans are characterized by an increased presence of infiltrating CD3+ T cells; however, the specific contributions of the different T cell subpopulations in coronary arteritis development remain unknown. Therefore, we sought to investigate the function of CD4+ and CD8+ T cells, Treg cells, and natural killer (NK) T cells in the pathogenesis of KD.

[1]  N. Sekarski,et al.  [Kawasaki disease: an update]. , 2018, Revue medicale suisse.

[2]  J. Burns,et al.  Review: Found in Translation: International Initiatives Pursuing Interleukin‐1 Blockade for Treatment of Acute Kawasaki Disease , 2017, Arthritis & rheumatology.

[3]  J. Newburger,et al.  Rationale and study design for a phase I/IIa trial of anakinra in children with Kawasaki disease and early coronary artery abnormalities (the ANAKID trial). , 2016, Contemporary clinical trials.

[4]  M. Fishbein,et al.  Role of Interleukin-1 Signaling in a Mouse Model of Kawasaki Disease–Associated Abdominal Aortic Aneurysm , 2016, Arteriosclerosis, thrombosis, and vascular biology.

[5]  Hyung-Bok Park,et al.  OPTIMAL CUTOFF VALUE OF ANNUAL CORONARY ARTERY CALCIUM SCORE PROGRESSION BY SERIAL CORONARY CALCIUM SCAN PREDICTING MAJOR ADVERSE CARDIOVASCULAR EVENTS IN ASYMPTOMATIC KOREAN POPULATION , 2016 .

[6]  J. Newburger,et al.  Kawasaki Disease. , 2013, Journal of the American College of Cardiology.

[7]  G. Weinstock,et al.  The transcriptional profile of coronary arteritis in Kawasaki disease , 2015, BMC Genomics.

[8]  M. Fishbein,et al.  IL-1 Signaling Is Critically Required in Stromal Cells in Kawasaki Disease Vasculitis Mouse Model: Role of Both IL-1&agr; and IL-1&bgr; , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[9]  S. Shulman,et al.  Kawasaki disease: insights into pathogenesis and approaches to treatment , 2015, Nature Reviews Rheumatology.

[10]  Chengrong Li,et al.  Regulatory T cell microRNA expression changes in children with acute Kawasaki disease , 2014, Clinical and experimental immunology.

[11]  J. Orenstein,et al.  An Evaluation of the Validity of the Animal Models of Kawasaki Disease Vasculopathy , 2014, Ultrastructural pathology.

[12]  X. Chen,et al.  IL-1 enhances expansion, effector function, tissue localization, and memory response of antigen-specific CD8 T cells , 2013, The Journal of experimental medicine.

[13]  Y. Okuno,et al.  Lack of CD4+CD25+FOXP3+ regulatory T cells is associated with resistance to intravenous immunoglobulin therapy in patients with Kawasaki disease , 2013, European Journal of Pediatrics.

[14]  Kei Takahashi,et al.  Kawasaki disease: basic and pathological findings , 2013, Clinical and Experimental Nephrology.

[15]  J. Orenstein,et al.  Three Linked Vasculopathic Processes Characterize Kawasaki Disease: A Light and Transmission Electron Microscopic Study , 2012, PloS one.

[16]  M. Fishbein,et al.  Interleukin-1&bgr; Is Crucial for the Induction of Coronary Artery Inflammation in a Mouse Model of Kawasaki Disease , 2012, Circulation.

[17]  T. Chatila,et al.  A requisite role for induced regulatory T cells in tolerance based on expanding antigen receptor diversity. , 2011, Immunity.

[18]  J. Choy,et al.  Inflammatory Cytokines Determine the Susceptibility of Human CD8 T Cells to Fas-mediated Activation-induced Cell Death through Modulation of FasL and c-FLIPS Expression* , 2011, The Journal of Biological Chemistry.

[19]  Y. Kim,et al.  Alteration of CD4+CD25+Foxp3+ T cell level in Kawasaki disease , 2011, Korean journal of pediatrics.

[20]  Kei Takahashi,et al.  Pathogenesis of Kawasaki disease , 2011, Clinical and experimental immunology.

[21]  Kei Takahashi,et al.  Kawasaki disease as a systemic vasculitis in childhood. , 2010, Annals of vascular diseases.

[22]  Y. Zu,et al.  The T helper type 17/regulatory T cell imbalance in patients with acute Kawasaki disease , 2010, Clinical and experimental immunology.

[23]  M. Fishbein,et al.  Involvement of Innate and Adaptive Immunity in a Murine Model of Coronary Arteritis Mimicking Kawasaki Disease1 , 2009, The Journal of Immunology.

[24]  D. Zajonc,et al.  Carbohydrate specificity of the recognition of diverse glycolipids by natural killer T cells , 2009, Immunological reviews.

[25]  W. Paul,et al.  IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiation , 2009, Proceedings of the National Academy of Sciences.

[26]  J. Orenstein,et al.  Searching for the cause of Kawasaki disease — cytoplasmic inclusion bodies provide new insight , 2008, Nature Reviews Microbiology.

[27]  J. Orenstein,et al.  RNA-Containing Cytoplasmic Inclusion Bodies in Ciliated Bronchial Epithelium Months to Years after Acute Kawasaki Disease , 2008, PloS one.

[28]  Y. Shoenfeld,et al.  Intravenous Immunoglobulin Therapy Affects T Regulatory Cells by Increasing Their Suppressive Function , 2007, The Journal of Immunology.

[29]  W. Daniel,et al.  Activated myeloid dendritic cells accumulate and co-localize with CD3+ T cells in coronary artery lesions in patients with Kawasaki disease. , 2007, Experimental and molecular pathology.

[30]  A. Rudensky,et al.  Foxp3 in control of the regulatory T cell lineage , 2007, Nature Immunology.

[31]  A. Rudensky,et al.  Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice , 2007, Nature Immunology.

[32]  M. Fishbein,et al.  TLR2 and MyD88 Contribute to Lactobacillus casei Extract–Induced Focal Coronary Arteritis in a Mouse Model of Kawasaki Disease , 2005, Circulation.

[33]  S. Shulman,et al.  CD8 T LYMPHOCYTES DO NOT EXPRESS CYTOTOXIC PROTEINS IN CORONARY ARTERY ANEURYSMS IN ACUTE KAWASAKI DISEASE , 2005, The Pediatric infectious disease journal.

[34]  Walter R Wilson,et al.  Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association , 2004, Circulation.

[35]  R. Yeung,et al.  Presence of IFN-γ Does Not Indicate Its Necessity for Induction of Coronary Arteritis in an Animal Model of Kawasaki Disease1 , 2004, The Journal of Immunology.

[36]  Toshiro Hara,et al.  CD25+CD4+ regulatory T cells in patients with Kawasaki disease. , 2004, The Journal of pediatrics.

[37]  P. Sopp,et al.  Differences in the induction of CD8+ T cell responses by subpopulations of dendritic cells from afferent lymph are related to IL‐1α secretion , 2001, Journal of leukocyte biology.

[38]  S. Crawford,et al.  CTLA-4 (CD152) Expression in T Cells during the Acute Stage of Kawasaki Disease , 2003, Pediatric Research.

[39]  S. Crawford,et al.  IgA plasma cell infiltration of proximal respiratory tract, pancreas, kidney, and coronary artery in acute Kawasaki disease. , 2000, The Journal of infectious diseases.

[40]  Hirao,et al.  Circulating CD4+CD8+ T lymphocytes in patients with Kawasaki disease , 1998, Clinical and experimental immunology.

[41]  H. Jäck,et al.  IgA plasma cells in vascular tissue of patients with Kawasaki syndrome. , 1997, Journal of Immunology.

[42]  L. Jonides,et al.  Kawasaki disease. , 1994, Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners.

[43]  T. Lehman.  Can we prevent long term cardiac damage in Kawasaki disease? Lessons from Lactobacillus casei cell wall-induced arteritis in mice. , 1993, Clinical and experimental rheumatology.

[44]  D. McCurdy,et al.  Coronary arteritis in mice following the systemic injection of group B Lactobacillus casei cell walls in aqueous suspension. , 1985, Arthritis and rheumatism.

[45]  M. Wolman,et al.  AN ANIMAL MODEL OF KAWASAKI DISEASE , 1984, Pediatric Research.

[46]  H. Yanagawa,et al.  A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. , 1974, Pediatrics.